SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Colby who wrote (7093)4/15/1998 6:50:00 PM
From: VLAD  Read Replies (1) of 23519
 
To all,

CNBC just did a piece on Viagra.

The following was reported:

1)Inquiries have been overwhelming.
2)Pfizer views the ED market as "essentially untapped".
3)Pfizer plans to spend over $35,000,0000 just to advertise to the consumer.
4)They said Pfizer has an excellent reputation for marketing.

At this point institutions might start seriously accumulating vivus stock. The over reaction is absurd.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News